Janiczek Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Janiczek Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$4.87K	Sell	10 -18	-64%	-$9.04K	﹤0.01%	744
2024 Q1	$15.1K	Buy	28 +20	+250%	+$10.9K	﹤0.01%	615
2023 Q4	$4.44K	Sell	8 -4	-33%	-$1.88K	﹤0.01%	765
2023 Q3	$5.25K	Hold	12	–	–	﹤0.01%	720
2023 Q2	$6.03K	Hold	12	–	–	﹤0.01%	631
2023 Q1	$5.79K	Hold	12	–	–	﹤0.01%	650
2022 Q4	$5.64K	Buy	12 +4	+50%	+$1.55K	﹤0.01%	637
2022 Q3	$3K	Hold	8	–	–	﹤0.01%	719
2022 Q2	$3K	Sell	8 -30	-79%	-$12.2K	﹤0.01%	735
2022 Q1	$21K	Buy	38 +15	+65%	+$7.89K	0.01%	441
2021 Q4	$15K	Sell	23 -1	-4%	-$628	﹤0.01%	520
2021 Q3	$15K	Buy	24 +2	+9%	+$1.34K	0.01%	499
2021 Q2	$14K	Sell	22 -1	-4%	-$552	0.01%	501
2021 Q1	$11K	Buy	23 +22	+2,200%	+$11K	﹤0.01%	508
2020 Q4	$0	Buy	+1	New	+$447	﹤0.01%	803
2020 Q3	–	Sell	-14	Closed	-$5K	–	681
2020 Q2	$5K	Buy	+14	New	+$4.05K	﹤0.01%	184

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janiczek Wealth Management's IDXX Position: Q2 2024 in Review

Janiczek Wealth Management reduced its Idexx Laboratories (IDXX) stake by 64% in Q2 2024, selling an estimated $9.04K and leaving 10 shares worth $4.87K. The position accounts for ﹤0.01% of the portfolio, ranked #744.

Janiczek Wealth Management first reported a position in IDXX in Q2 2020 and has held it in 16 quarters since. The position peaked at $21K in Q1 2022. 1,109 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

Janiczek Wealth Management held 10 shares of Idexx Laboratories worth $4.87K as of Q2 2024.
Janiczek Wealth Management sold 18 Idexx Laboratories shares in Q2 2024, an estimated $9.04K.
Idexx Laboratories made up ﹤0.01% of Janiczek Wealth Management's portfolio in Q2 2024, its #744 holding.
Janiczek Wealth Management first reported a position in Idexx Laboratories in Q2 2020 and has held it in 16 quarters since.
Janiczek Wealth Management's Idexx Laboratories position peaked at $21K in Q1 2022.
1,109 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.